Medical Technology

@xconomy.com 3 years ago

Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D

@xconomy.com 3 years ago

FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy

@DrSeeboth 3 years ago

This #technology would probably also enable us to identify neurological and muscular gait disorders. #medicine #future #ML #wearables #DHPSP #MachineLearning https://twitter.com/dhpsp/status/1288670220366811138

@techcrunch.com 5 years ago

Tackling the $190 billion physical therapy market, Sword Health raises $8 million from Khosla Ventures